The state of the union is … busy

FHS
March 7, 2024
8:18 pm

President Joe Biden is working to lay out his health agenda for a second term, even as Congress races to finish its overdue spending bills for the fiscal year that began last October.

Edwards pushes back on Medtronic’s head-to-head TAVR trial

Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. Medtronic went on the offensive last week

April 15, 2024

Anthos to stop factor XI trial in atrial fibrillation early after ‘overwhelming benefit’

Anthos Therapeutics announced Monday morning that it is stopping a Phase II study of its next-generation anticoagulant abelacimab in atrial fibrillation as a result of

September 19, 2023

Investigational protein replacement protects neonatal mice from deadly intestinal disease

Scientists from Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago and colleagues found that an investigational protein replacement

February 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.